FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: PATIENT-FOCUSED DRUG DEVELOPMENT: WORKSHOP #2 TO DISCUSS METHODOLOGIC AND OTHER CHALLENGES RELATED TO PATIENT EXPERIENCE DATA; PUBLIC WORKSHOP; REQUEST FOR COMMENTS

WASHINGTON, Aug. 28 -- Food and Drug Administration has issued a notice called: Patient-Focused Drug Development: Workshop #2 To Discuss Methodologic and Other Challenges Related to Patient Experience Data; Public Workshop; Request for Comments.

The notice was published in the Federal Register on Aug. 28 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled "Patient-Focused Drug Development: Workshop #2 to Discuss Methodologic and Other Challenges Related to Patient Experience Data." The purpose of the public workshop is to discuss methodological challenges related to patient experie...